Maravai LifeSciences Holdings, Inc.
MRVIMaravai LifeSciences is a life sciences company that provides specialized products and services essential for the development of drug therapies, vaccines, and diagnostics.
Earnings
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$48.7M
EPS estimate-$0.05
Valuation & ratios
Segments
By geography
Competitors
By market cap
By revenue growth
By net margin
Profile
Maravai LifeSciences is a life sciences company that provides specialized products and services essential for the development of drug therapies, vaccines, and diagnostics. The company focuses on enabling biopharmaceutical research and production through high-quality nucleic acids and protein detection solutions.
Competitive position
A leading provider of specialized nucleic acids and impurity testing reagents for the biopharmaceutical industry.
GeographiesGlobal
Customer segmentsBiopharmaceutical companies, Academic research institutions, Diagnostics companies
Business modelDirect-to-customer manufacturing, B2B product sales
SuppliersChemical raw material suppliers, Specialized laboratory equipment manufacturers
CustomersDrug developers, Vaccine manufacturers, Clinical diagnostic laboratories
CountryUnited States of America
Listed2020
Employees570.0
CEOBernd Brust
SectorHealthcare
IndustryBiotechnology
Websitemaravai.com
FilingsSEC EDGAR
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s market cap?
- Maravai LifeSciences Holdings, Inc. (MRVI) has a market capitalization of $986.8M and trades on NASDAQ.
- What is Maravai LifeSciences Holdings, Inc.'s revenue and profitability?
- Maravai LifeSciences Holdings, Inc. generated $204.7M in trailing twelve-month revenue with a net loss of $104.6M, representing a net margin of -51.1%. Gross margin stands at 29.3%, with free cash flow of -$52.6M. These figures are based on the Q1 2026 filing.
- Who are Maravai LifeSciences Holdings, Inc.'s competitors?
- Maravai LifeSciences Holdings, Inc.'s key competitors include Danaher Corporation, Thermo Fisher Scientific, Repligen Corporation, and others. These companies compete in similar markets and product categories.
- What subsidiaries does Maravai LifeSciences Holdings, Inc. have?
- Maravai LifeSciences Holdings, Inc.'s subsidiaries include TriLink BioTechnologies, Cygnus Technologies.
- Where is Maravai LifeSciences Holdings, Inc. headquartered?
- Maravai LifeSciences Holdings, Inc. is headquartered in United States of America and employs approximately 570 people. It has been publicly traded since 2020.
